Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuichi Ushijima

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Journal of Applied Clinical Medical Physics|April 16, 2026
Optimization of pulmonary blood flow analysis method using dynamic chest radiographyTasuku Nakajima, Ryuichi Ushijima, Rie Tanaka
Medicina (Kaunas, Lithuania)|May 27, 2023
Combination Treatment of Balloon Pulmonary Angioplasty and Direct Oral Anticoagulant in a Patient with Chronic Thromboembolic Pulmonary Hypertension Complicated by Protein S DeficiencyToshihide Izumida, Teruhiko Imamura, Ryuichi Ushijima, et al.
International Heart Journal|January 18, 2026
Impact of Multidisciplinary Interventions on the Enhancement of Guideline-Directed Medical Therapy and Clinical Education in Hospitalized Heart Failure PatientsHiroshi Onoda, Teruhiko Imamura, Ryuichi Ushijima, et al.
Medicina (Kaunas, Lithuania)|February 26, 2025
Efficacy of Inhaled Treprostinil in a Patient with Systemic Sclerosis-Associated Pulmonary Hypertension and Interstitial Lung Diseases Refractory to Conventional Intravenous EpoprostenolYuki Hida, Teruhiko Imamura, Ryuichi Ushijima, et al.
Autonomic Neuroscience : Basic & Clinical|January 3, 2020
Sympathetic overactivation predicts body weight loss in patients with heart failureShuji Joho, Ryuichi Ushijima, Masaki Nakagaito, et al.
Journal of Cardiology|November 14, 2018
Relation between prognostic impact of hyperuricemia and sympathetic overactivation in patients with heart failureShuji Joho, Ryuichi Ushijima, Masaki Nakagaito, et al.
Journal of Clinical Medicine|July 29, 2023
Prognostic Impact of the Increase in Cardiac Troponin Levels during Tafamidis Therapy in Patients with Transthyretin Cardiac AmyloidosisMakiko Nakamura, Teruhiko Imamura, Ryuichi Ushijima, et al.
Circulation Reports|March 11, 2021
Comparison of Canagliflozin, Dapagliflozin and Empagliflozin Added to Heart Failure Treatment in Decompensated Heart Failure Patients With Type 2 Diabetes MellitusMasaki Nakagaito, Shuji Joho, Ryuichi Ushijima, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 13, 2016
Sympathetic Nerve Activity Efferent Drive and Beta-Blocker Treatment　- Effect of Interaction in Systolic Heart FailureShuji Joho, Takashi Akabane, Ryuichi Ushijima, et al.
Journal of Cardiac Failure|October 9, 2012
Effect of adaptive servoventilation on muscle sympathetic nerve activity in patients with chronic heart failure and central sleep apneaShuji Joho, Yoshitaka Oda, Ryuichi Ushijima, et al.
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Journal of Applied Clinical Medical Physics|April 16, 2026
Optimization of pulmonary blood flow analysis method using dynamic chest radiographyTasuku Nakajima, Ryuichi Ushijima, Rie Tanaka
Medicina (Kaunas, Lithuania)|May 27, 2023
Combination Treatment of Balloon Pulmonary Angioplasty and Direct Oral Anticoagulant in a Patient with Chronic Thromboembolic Pulmonary Hypertension Complicated by Protein S DeficiencyToshihide Izumida, Teruhiko Imamura, Ryuichi Ushijima, et al.
International Heart Journal|January 18, 2026
Impact of Multidisciplinary Interventions on the Enhancement of Guideline-Directed Medical Therapy and Clinical Education in Hospitalized Heart Failure PatientsHiroshi Onoda, Teruhiko Imamura, Ryuichi Ushijima, et al.
Medicina (Kaunas, Lithuania)|February 26, 2025
Efficacy of Inhaled Treprostinil in a Patient with Systemic Sclerosis-Associated Pulmonary Hypertension and Interstitial Lung Diseases Refractory to Conventional Intravenous EpoprostenolYuki Hida, Teruhiko Imamura, Ryuichi Ushijima, et al.
Autonomic Neuroscience : Basic & Clinical|January 3, 2020
Sympathetic overactivation predicts body weight loss in patients with heart failureShuji Joho, Ryuichi Ushijima, Masaki Nakagaito, et al.
Journal of Cardiology|November 14, 2018
Relation between prognostic impact of hyperuricemia and sympathetic overactivation in patients with heart failureShuji Joho, Ryuichi Ushijima, Masaki Nakagaito, et al.
Journal of Clinical Medicine|July 29, 2023
Prognostic Impact of the Increase in Cardiac Troponin Levels during Tafamidis Therapy in Patients with Transthyretin Cardiac AmyloidosisMakiko Nakamura, Teruhiko Imamura, Ryuichi Ushijima, et al.
Circulation Reports|March 11, 2021
Comparison of Canagliflozin, Dapagliflozin and Empagliflozin Added to Heart Failure Treatment in Decompensated Heart Failure Patients With Type 2 Diabetes MellitusMasaki Nakagaito, Shuji Joho, Ryuichi Ushijima, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 13, 2016
Sympathetic Nerve Activity Efferent Drive and Beta-Blocker Treatment　- Effect of Interaction in Systolic Heart FailureShuji Joho, Takashi Akabane, Ryuichi Ushijima, et al.
Journal of Cardiac Failure|October 9, 2012
Effect of adaptive servoventilation on muscle sympathetic nerve activity in patients with chronic heart failure and central sleep apneaShuji Joho, Yoshitaka Oda, Ryuichi Ushijima, et al.
Pageof 8